PCRX

PCRX Total Non-Current Assets

$628.77MQuarterly · USD

Period ending:

PCRX FY Non-Current AssetsUSD
PCRX FY Non-Current Assets2008-12-31: $31.18M2009-12-31: $31.41M2010-12-31: $35.51M2011-12-31: $30.84M2012-12-31: $51.13M2013-12-31: $63.07M2014-12-31: $111.82M2015-12-31: $137.04M2016-12-31: $148.38M2017-12-31: $237.26M2018-12-31: $211.38M2019-12-31: $422.51M2020-12-31: $622.89M2021-12-31: $1.21B2022-12-31: $1.18B2023-12-31: $1.06B2024-12-31: $808.39M2025-12-31: $716.94M$1.21B$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX total non-current assets history

Long-term assets expected to provide value beyond one year. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc Total Non-Current Assets — Annual fiscal periods (USD)
Period endingTotal Non-Current Assets (USD)
716,943,000
808,386,000
1,064,392,000
1,182,866,000
1,209,305,000
622,890,000
422,508,000
211,384,000
237,261,000
148,377,000
137,041,000
111,815,000
63,069,000
51,132,000
30,841,000
35,507,000
31,405,000
31,184,000

Compare total non-current assets

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.